Status:
NOT_YET_RECRUITING
Reducing Missed Appointments
Lead Sponsor:
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Conditions:
Neurodevelopmental Disorders
Eligibility:
All Genders
1-24 years
Phase:
PHASE3
Brief Summary
There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching...
Detailed Description
Aim 1: To test messaging strategies aimed at reducing missed appointments, via a randomized trial, across two different Kennedy Krieger outpatient clinics. Using the reminder system timeline and conta...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All patients who are scheduled to be seen within the center for autism or the center for neuropsychological and psychological assessment for evaluation appointments will be automatically enrolled in the reminder message portion of the intervention trial.
- Patients who are at elevated risk within the center for neuropsychological and psychological assessment are automatically enrolled in the patient navigator portion of the intervention trial.
- Exclusion criteria:
- None for the messaging portion of the study
- For patient navigation, patients \>18 years of age will be excluded.
Exclusion
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06915480
Start Date
January 1 2026
End Date
December 1 2027
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kennedy Krieger Institute
Baltimore, Maryland, United States, 21211